Over 1,000 fertility specialists gathered in Doha, Qatar last week for the 31st Middle East Fertility Society (MEFS) Scientific Meeting. From November 21-23, 2024, the Sheraton Grand Doha became a hub of knowledge exchange in reproductive medicine, with SILK Medical‘s exhibition drawing significant attention from international practitioners.
The clinic’s booth featured comprehensive displays highlighting advanced fertility technologies, including the AI-powered EmbryoScope and genetic testing programs. Conference attendees showed particular interest in SILK Medical’s impressive statistics: 75%+ first-attempt pregnancy rates in guaranteed programs and 100% live birth rates in guaranteed surrogacy programs.
SILK Medical’s representatives engaged with fertility specialists from across the Middle East region, discussing the clinic’s comprehensive approach to reproductive care. The team demonstrated how Georgian healthcare legislation creates favorable conditions for international patients seeking fertility treatments.
Beyond showcasing technical capabilities, the conference provided valuable networking opportunities. The SILK Medical team connected with leading fertility experts and potential clinical partners, expanding their professional network across the Middle East and North Africa region.
The clinic’s participation reinforced its position in global reproductive medicine. Visitors to booth #11 learned about SILK Medical’s range of fertility solutions, from standard IVF procedures to complex genetic testing options.
For those who couldn’t attend MEFS 2024, SILK Medical maintains its commitment to accessibility through:
- Online consultations
- Clinic visits in Tbilisi
- WhatsApp and email communication
- Personalized treatment planning
Contact SILK Medical to discuss fertility treatment options or learn more about the programs presented at MEFS 2024:
Website: silkmedicalclinic.com
Email: connect@silkmedical.ge
WhatsApp: +995591041857
English